Results 141 to 150 of about 24,911 (203)

Disordered DNA methylation leads to targetable transcriptional plasticity in ATRT. [PDF]

Acta Neuropathol Commun
Tetens AR, Findlay TR, Craig-Schwartz J, Liapodimitri A, Camacho O, Skalitzky KO, Idrizi A, Tryggvadottir R, Lunsford K, Raabe EH, Koldobskiy MA.   +10 more
europepmc   +1 more source

Correspondance: Venetoclax combined with FLAG-based chemotherapy induces rapid and deep responses in early T-cell precursor lymphoblastic leukemia/lymphoma. Report of two cases and review of the literature. [PDF]

Ann Hematol
Dereme J, Segot A, Nabergoj M, Dewarrat N, Basset V, Blum S, Tsilimidos G.   +6 more
europepmc   +1 more source

Identification of a Diagnostic Gene Signature Associated with Centrosome Amplification in Pressure Injuries: A Cross-Sectional Transcriptome and Machine Learning Study. [PDF]

J Inflamm Res
Li S, Shen H, Li K, Wang X, Sun Z, Li Y, Yuan Y.   +6 more
europepmc   +1 more source

American Society of Hematology 2025 guidelines for treating newly diagnosed acute myeloid leukemia in older adults. [PDF]

Blood Adv
Sekeres MA, Mattison R, Artz A, Baer MR, Chua CC, Demichelis-Gómez R, Egan PC, Fletcher L, Foucar C, Garcia JS, Gilberto L, Gómez de León A, Lancet J, Loh KP, Malcovati L, Marini B, Platzbecker U, Sorror ML, Tinsley-Vance S, Treitz J, Oliveros MJ, Ibrahim S, Roldan Y, Guyatt G, Brignardello-Petersen R.   +24 more
europepmc   +1 more source

The effect of decitabine on human induced pluripotent stem cells (hiPSCs) derived CD34⁺ cells expansion and the megakaryocytes generation and maturation. [PDF]

Am J Stem Cells
Liu Y, Zhang H, Li Y, Zhao C.
europepmc   +1 more source

TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a comprehensive overview of targeted approaches. [PDF]

Front Oncol
Deshpande S, Li WF, Song J, Forsberg M, Cerchione C, Martinelli G, Konopleva M.   +6 more
europepmc   +1 more source

Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML. [PDF]

Hemasphere
Fiskus W, Mill CP, Piel J, Collins M, Hentemann M, Cuglievan B, Birdwell CE, Das K, Davis JA, Hou H, Jain A, Malovannaya A, Flores LB, Kadia TM, Daver N, Sasaki K, Takahashi K, Hammond D, Wang J, Loghavi S, Su X, DiNardo CD, Delwel R, Bhalla KN.   +23 more
europepmc   +1 more source

SEPT9 methylation as a diagnostic and predictive biomarker in the progression of ductal carcinoma in situ to invasive breast cancer. [PDF]

Sci Rep
Guo Y, Zhou X, Xu H, Wang G.
europepmc   +1 more source

The combination therapy with venetoclax in therapeutic strategy of acute lymphoblastic leukemia. [PDF]

Discov Oncol
Shamahmood MN, Yousefi MJ, Miri A, Mezginejad F.   +3 more
europepmc   +1 more source

Integrating Targeted Therapies into AML Frontline Therapy: Who Gets What and What Does the Future Hold? [PDF]

Cancers (Basel)
Schreiber J, Hopfinger G, Gleixner KV.
europepmc   +1 more source